Preclinical Imaging 2020 Global Market Key Players, Analysis and Forecast to 2023

 Market Research Future with their unique quality of simplifying the market research study, announces a deep study report on “Preclinical Imaging Market Research Report – Forecast to 2023” Gives industry size, top players and worldwide demand

Preclinical Imaging Market Scenario

Global preclinical imaging market is expected to grow significantly over the forecast period. It is anticipated that the market held value of USD 2.01 billion in 2017 and is projected to grow at a CAGR of 6.3% over the forecast period.

The factors such as technological advancements in the field of molecular imaging, increasing market demand for non-invasive small-animal imaging techniques, and increasing funding to support preclinical researches are expected to propel the growth of the market. However, strict regulations in preclinical research and high installation and operational costs associated with preclinical imaging modalities hamper the market growth over the forecast period.

Also Read : https://www.marketwatch.com/press-release/covid-19-impact-analysis-preclinical-imaging-market-trends-2020-global-size-industry-growth-share-regional-revenue-top-company-profile-2020-08-13

Strict legislation in preclinical science, however, as well as high deployment and maintenance costs associated with preclinical imaging modalities impede market development over the poised period. In addition, the limitations imposed on animal testing due to laws implemented by organisations defending animal rights are the main factors impeding business development.

Preclinical Imaging Market Segmental Analysis

The global preclinical imaging market has been analyzed based on the reagent, modality, and region.

The modality-based segmentation of the market comprises into optical imaging systems, nuclear imaging systems, micro-ultrasound, micro-MRI, photoacoustic imaging, micro-CT, and magnetic particle imaging. The field of optical imaging systems is predicted to continue its dominance over the market share as it recorded in 2017.

The reagent-based segmentation of the market comprises preclinical ultrasonic contrast agents, preclinical optical imaging reagents, preclinical MRI contrast agents, preclinical nuclear imaging reagents, and preclinical CT contrast agents. The field of preclinical optical imaging reagents is predicted to maintain its winning streak over the prognosis period.

 

Preclinical Imaging Market Regional Overview

The Asia-Pacific preclinical imaging market is consists of developing economies like China, the Republic of Korea, India , Japan, Australia, and the rest of the Asia-Pacific region. The Asia-Pacific region is slated to be the region with the highest growth. the high demand for remote sensing services in various applications, such as precision farming, 3D terrain model building, damage evaluation, pipeline tracking, geohazard modeling, resource extraction, and security and intelligence is leading the Asia Pacific region market to secure the fastest CAGR.

Driven by growing investments in numerous military and commercial satellite projects, North America is second to the European market in the demand for remote sensing satellites. The North American industry is powered primarily by an growing need for remote sensing services in diverse industries and the presence of major public and private companies.

Europe is slated to hold the second-largest regional growth in the global market for preclinical imaging. The growing success of this region’s demand is resulting in further R&D investments towards the promotion of preclinical research. On the other hand, the Middle East & Africa is observing gradual growth and is slated to acquire for the lowest market share of the preclinical imaging market.

Preclinical Imaging Market Competitive Dashboard

Some of the eminent players in the global preclinical imaging market are Bruker Corporation (US), MR Solutions (UK), PerkinElmer Inc. (US), Fujifilm Holdings Corporation (Japan), Milabs B.V. (The Netherlands), Mediso Ltd. (Hungary), LI-COR, Inc. (US), Miltenyi Biotec GmbH (Germany), Aspect Imaging (Israel), and Trifoil Imaging (US).

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/preclinical-imaging-market-7365 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Statistical Report, Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Hadapsar, Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

 

Europe CBCT Dental Imaging Market: Information, Analytical Insights and growth of 2020 – 2023

 

Europe CBCT Dental Imaging Market- Overview

Over the past few years in the field of dentistry, radiographic imaging has evolved from a conventional two-dimensional technique to a three-dimensional modality. Cone beam computerized tomography (CBCT) has been referred as the gold standard for diagnostic maxillofacial imaging. There have been an increasing references in the dental literature towards the utility of CBCT in clinical dental practice. Dental cone beam computed tomography (CT) is a distinctive type of X-ray machine used in circumstances where regular dental or facial X-rays are not sufficient. This type of computed tomography scanner uses a special type of technology to produce three dimensional (3-D) images of oral structures, soft tissues, nerve paths, and bones in the craniofacial region in a single scan.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/4137 

The technology is used to produce three dimensional (3-D) images of the teeth, soft tissues, nerve pathways, and bones in a single scan. The CBCT dental imaging industry is growing rapidly. Increasing funding for research is leading to new and innovative device development that is driving the market growth. Rapid adoption of advanced devices by dental professionals for accurate and effective diagnosis is also important for the market growth. The use of 3D radiographic imaging in orthodontics is growing rapidly which has fuelled the market demand. Changing technology and healthcare practices also play major role in the growth of this market. Some other factors include growing aging population, rising awareness, investment made by hospitals for technology up gradation, increasing cases of gum diseases and sport injuries that are spurring the market growth.

Europe CBCT Dental Imaging market is expected to grow at the CAGR of ~ 11.41% during the forecast period till 2023. According to a recent study report published by the Market Research Future, the Europe CBCT Dental Imaging market share is expected to gain eminence over the forecast period. The market is forecasted to demonstrate a steady growth by 2023, surpassing its previous growth records in terms of value with a constant CAGR during the anticipated period (2017–2023).

Europe CBCT Dental Imaging Market - Competitive Analysis

The market for CBCT Dental Imaging is characterised by the presence of several well-established and small players, the global market of CBCT Dental Imaging appears to be highly competitive and fragmented. Major players are increasingly expanding their footprint in the emerging nations, making it putting pressure on the regional players, especially in terms of features such as type, product portfolios, and pricing. The market is witnessing intensified competition which is expected to get more intensified further during the forecast period. The key players in the industry are adopting to compete with one another directly and indirectly with other ecosystem players. The established companies are busy in acquiring companies and entering into partnership with other ecosystem players. The Market Entropy activities in this market includes Mergers & Acquisitions, Collaboration & Expansion, Product Development and Launch and Others.

Since, the market started gaining attraction; companies across the globe have been striving hard to bring about innovations in 3D radiographic imaging devices and services, depending upon the demand of the consumers. In light of this trend, the market is gaining considerable momentum through the opportunities for personalization and customization which the new entrants have to offer.

For instance, in March 2015; KaVo consistently developing its product 3D eXam DVT platform. The system is equipped with all necessary functions for the production of 3D images of superior quality. The KaVo 3D eXam+ was specially developed for volume tomography and meets the highest requirements for 3D diagnostics.

Increasing mergers and acquisitions has also supported the growth of the market. Such as in February 2016, DENTSPLY International Inc. and Sirona Dental Systems, Inc. proclaim completion of remaining regulatory milestones for proposed merger.

Therefore, the growing key business strategies will help the key competitors to expand their presence in various parts of the Europe region for their competitive products and will has spurred the growth of the market.  

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/europe-cbct-dental-imaging-market-4137 

Grand Mal Seizure Market – A market with high CAGR and return on investment by 2023

 

Market Highlights

Epilepsy is a group of neurological disorders characterized by brief, involuntary episodes of vigorous shaking of a part or complete body, which may cause loss or disturbance of consciousness. About 24 million people around the globe in 2015 had epilepsy and grand mal seizures was the most common among the patients. Grand mal seizures or tonic/clonic seizures are a type of generalized seizures, which affect the entire brain and are the most common type of epileptic seizures. The factors causing grand mal seizures are-neurotransmitter imbalances-which are also influenced by fatigue, lack of sleep, hypertension, stress, intense lighting, rapid motion, blood sugar level, anxiety, etc.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/4087 

The market for grand mal seizures will respond very positively for any novel acting drug molecules due to poor efficacy and efficiency of the available drugs. The Gamma Aminobutyric Acid Modulators and ion channel blockers hold the largest market share but the sizeable segment of patients respond very poorly to these drugs. The market for grand mal seizures also undergoes from the high cost of clinical trials and extensive post market surveillance. Most of the drugs also have very similar mechanism of action, which assures the introduction of novel drugs with a different mechanism of action, will acquire maximum share, and achieve leading position at minimum marketing cost. The support for drug research and awareness created by the social and government bodies is also expected to help the global grand mal seizures market.

A significant growth in sensitivity towards patient safety and regulatory compliance may hamper the market growth, especially, in the US. Furthermore, due to rising stringency of FDA such as pre-market approval and focus on evidence for efficacy, efficiency as well as patient safety may slow the growth of the market.

Global Grand Mal Seizure Market Players

Key players profiled in the report are Pfizer, Inc., Johnson & Johnson Services, Inc., UCB Celltech, Abbott Laboratories, GlaxoSmithKline plc, Novartis AG, Sanofi, Shire Pharmaceuticals Limited, and Teva Pharmaceutical Industries

Taste the market data and market information presented through more than 50 market data tables and figures spread over 80 pages of the project report. Avail the in-depth table of content (TOC) & market synopsis on “Global Grand mal seizure market” Research Report – Forecast till 2023.

Segmentation

The global grand mal seizure market has been segmented on the basis of drug generation, drug class, surgery, diagnosis, and end users. Based on drug generation, the market has been segmented as first generation, second generation, and third generation. Based on the drug class, the market has been segmented as barbiturates, hydantoin, cyclic gaba analogues, phenyltriazine, iminostilbenes, aliphatic carboxylic acid, benzodiazepines, and others. Based on the surgery, the market has been segmented as resective surgery, multiple subpial transection, hemispherectomy, corpus callosotomy, and others. Based on the diagnosis, the market has been segmented as electroencephalogram (EEG), magnetic resonance imaging (MRI), computed tomography (CT), blood tests, and others. Based on the end users, the market has been segmented as hospitals, neurological centers, academic and research center, and others.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/grand-mal-seizure-market-4087 

Dental Infection Treatment Market – A market with high CAGR and return on investment by 2023

 

Global Dental Infection Treatment Market   - Overview

Dental infection or tooth abscess is an infection of teeth, gums and associated tissue caused by a bacterial infection. Tooth abscess leads to pus formation and if left untreated can lead to serious, even life-threatening, complications. The symptoms of a tooth abscess include severe, persistent, throbbing pain in the tooth which can radiate to the jawbone, neck and other associated parts of the head, fever, swelling in cheeks, swollen lymph nodes, sensitivity to hot and cold foods etc. The spread of infection results in foul smell and foul-taste in mouth. The periapical tooth abscess is the most dangerous as bacteria invade the dental pulp which is the innermost part of the tooth that contains blood vessels, nerves and connective tissue.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/4068 

The market for dental infection treatment is highly fragmented due to large number of players especially in the drugs segment which has put pressure on the profit margin, rise of low quality and low cost drug products manufactured by companies operating from regions with poor regulatory framework which reduces the market of quality drug products. Also the market for dental infection treatment is highly dependent on product development strategy such as high quality fills and cements. The drug segment is growing at a slow pace due to saturation of the market. Considering all these factors, the market for dental infection treatment is expected to grow at a CAGR of ~ 8.6 % during 2017-2023.

According to the Centres for Disease Control and Prevention, in 2014, 19% of the children aged 5-19 years and 31% of adults aged 20-44 have untreated dental caries. According to the WHO, worldwide, 60–90% of school children and nearly 98% of adults have dental cavities, which often leading to pain and discomfort. According to findings from the Centres for Disease Control and Prevention, (2012), one out of every two American adults aged 30 and over has periodontal disease. According to findings from the Centres for Disease Control and Prevention in 2012, approximately 91 % of US adults aged 20–64 had dental caries in permanent teeth.

 Global Dental Infection Treatment Market   - Competitive Analysis

Kerr Corporation, Patterson Dental Supply, Inc., Henry Schein, Inc., Pfizer .Inc, Endo Pharmaceuticals, Johnson & Johnson, Taj Pharmaceuticals Limited, Septodont Healthcare India Pvt. Ltd., Bayer HealthCare, Ultradent Products Inc., Bristol-Myers Squibb, Daiichi Sankyo are some of the prominent players at the forefront of competition in the Global Dental Infection Treatment Market and are profiled in MRFR Analysis.   

Aug-16   - Henry Schein had announced that it had acquired 80% ownership of Marrodent, which is a full service dental distributer of Poland, thus marking Henry Schein’s entry into the dental market of Poland.

Jul-16 -  Kitron signed supply agreement with Dentsply Sirona. This agreement will add Kitron as a new supplier for Dentsply Sirona

Jun-16 - Septodont Company had launched a bioactive and biocompatible root canal sealer named BioRoot RCS.

May-16  - 3M acquired Semfinder, a leading developer of precise semantic coding of medical services.

May-16  - 3M     Knifeless Tech Systems was acquired by 3M. The business acquired is an installation tool used to cut self-adhesive films applied to vehicle wraps.

Apr-16    - Straumann acquired 51% residual ownership of Neodent. This deal augments Straumann's presence in the tooth replacement sector in the Latin American region and Brazil, which is the second largest market for implant dentistry.

Feb-16   - Septodont     Company acquired DLA, an injectable dental anesthetic manufacturing plant from Dentsply International.

Global Dental Infection Treatment Market   - Regional Analysis

US accounts for the maximum market share due to greater use of medications and greater expenditure on healthcare. The faster market uptake of new technology and devices in the US is also an important driver of the market for global dental infection treatment. The presence of large device companies in the developed regions is also a major driver of the market. Europe is the second largest market due to large disposable income and rising awareness regarding the health hazards of this condition. Asia Pacific region is expected to have the most future potential and it is estimated to be led by China and India. The Middle East & Africa market is led by the gulf nations particularly Saudi Arabia and UAE. The regions of Africa are expected to witness a moderate growth due to poor economic and political conditions and poor healthcare penetration.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/dental-infection-treatment-market-4068 

Europe Dental Software Market to Witness Widespread Expansion During 2020 to 2023

 Market Scenario:

The Europe Dental Software market is expected to witness high growth in the coming years. The demand for dental software is dignified by improving process quality, patient satisfaction and speeding up the process for the treatments provided by dental organizations, and dental institutes. The growing availability of electronic data offers practitioners increased opportunities for reusing clinical data for research and quality improvement.
Considering the scenario of the Europe Dental Software market share, the total market was US$ 488.6 million in 2016 and expected to reach US$ 861.0 million by 2023.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/3263 

Key Players for Europe Dental Software Market:          
Some of the key players in this market are: Carestream Health, Inc (US), Dentsply Sirona (US), Elite Computer Italia (OrisLine Group) (italy), Henry Schein, Inc (US), KaVo Dental GmbH (Germany), PLANMECA OY (Finland)
Segments:
Europe Dental Software Market has been segmented on the basis of type which comprise Practice Management Software, Patient Communication Software, Treatment Planning Software, Patient Education Software, and Dental Imaging Software. Patient management segment was holding largest market share. On the basis of application, it is segmented into Clinical Application, Administrative. Clinical application segment is dominating The European dental software market by application. On the basis of deployment, it is segmented into On-Premise Model, and Web-Based/ Cloud-Based Model. On-premise model is leading in this segment. On the basis of End User it is segmented into Hospitals & Clinics, Academics & Research Institutes. Hospitals and clinics was holding largest market share in 2016.

Regional Analysis of Europe Dental Software Market:     
Considering the scenario of Europe Dental Software market, Germany was holding largest market share of 20.6% in 2016 and is expected to reach 165.9 million by 2023. France is second largest country in Europe Dental Software market. UK is expected to grow at a CAGR of 7.6% during 2017-2023. On the other hand. Eastern Europe Dental Software market is growing significantly and is expected to grow at a CAGR of 7.4% during the forecast period.  

The report for Europe Dental Software Market of Market Research Future comprises extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/europe-dental-software-industry-3263 

Rabies Diagnostics Market Foreseen to Draw a Promising Growth by 2023

 

Market Highlights

Rabies is a life treating a viral disease which is caused by the biting of an infected rabid animal.  It is fever, headache, muscle aches, loss of appetite, nausea, and tiredness to the infected animal or human. The surge in the prevalence of rabies, increasing awareness about rabies, and a rising number of pet animals are expected to drive the global rabies diagnostics market growth during the forecast period. Moreover, ongoing research and development activities by non-profit organizations and aggressive strategies by top players such as mergers, expansion, and collaboration for the development of new products and new product launches by major players are also boosting the growth of the market. According to the report published by World Organization for Animal Health, Asia-Pacific region is hugely affected by rabies owing to the increasing cases of rabies, in Asia approximately 31000 deaths were caused by rabies which is 56% of the total cases. 

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/7796 

The high costs associated with the diagnostic, absence of awareness about rabies and scarcity of skilled workforce may hamper the growth of the market during the assessment period.

Regional Analysis

The market is likely to dominate by Asia-Pacific during the forecast period owing to the improving healthcare infrastructure, increasing investments in the healthcare sector and expansions by market players in the region. Also, a country such as India and China are considering the fastest growing region due to a government focused toward adopting new technology, and the best treatment option from a developed country.

The Americas are expected to be the second-largest market in the global rabies diagnostics market due to the rising collaborative activities by major players, raising awareness about rabies, the involvement of non-profit organization to control rabies, and well-established healthcare infrastructure.

The European market is likely to hold a significant market share in the rabies diagnostics market. The government funding, well-established healthcare sector, and support of the healthcare sector coupled with increasing research and development are responsible for the growth of this market in the region.

The market in the Middle East & Africa is expected to account for the smallest share of the global rabies diagnostics market due to an underdeveloped healthcare sector, lack of technical knowledge, and poor medical facilities.

Segmentation

The global rabies diagnostics market has been segmented on the basis of method, technology, end-user, and region.

Based on method, the market has been classified as a fluorescent antibody test (FAT), immunohistochemical test, amplification methods, histologic examination, and serology tests. Global rabies diagnostics market on the basis of technology has been segmented into ELISA/immunohistochemistry, chromatography techniques, PCR, and others.

Based on market has been segmented into hospitals, diagnostic centers, cancer palliative care clinics, and others.

Key Players

Some of the key players in the global rabies diagnostics market are Bio-Rad Laboratories, Inc., Merck KGaA, Aviva Systems Biology Corporation, Creative Diagnostics, Demeditec Diagnostics GmbH, Abbexa Ltd., Norgen Biotek Corp., BioNote, Inc., Express Biotech International Inc., MyBioSource.com., and BioGen Technologies

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/rabies-diagnostics-market-7796 

Enteral Feeding Devices Market: Information, Analytical Insights and growth of 2020 – 2023

 Market Highlights

The global enteral feeding devices market size held a market value of USD 2,302.4 million in 2017 and is projected to grow at a CAGR of 6.1% over the forecast period. Enteral feeding is the direct delivery of nutrients into the gastrointestinal tract (GIT) via a tube which is placed into the duodenum, jejunum or stomach through mouth, nose or percutaneous route. Major factors driving the market growth are globally growing geriatric population coupled with the rising burden of chronic diseases, increasing shift from parenteral to enteral nutrition, and mounting incidence of preterm births. For instance, according to the World Health Organization (WHO), in 2001, chronic diseases contributed around 60% of the 56.5 million total reported deaths across the world and approximately 46% of the global burden of disease, which is projected that, by 2020, chronic diseases will account for almost three-quarters of all deaths worldwide. In contrast, complications associated with enteral feeding devices including inadvertent dislodgement of tubes and stringent reimbursement policies are anticipated to restrain the market growth during the next five years. Mounting technological advancement in feeding pumps such as enhanced portable pump designs with reduced risk of complications and is augmenting the market growth.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/7828 

Regional Analysis

The global enteral feeding devices market has been segmented by region into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. Based on region, the Americas would command the market over the forecast period pertaining to the presence of sophisticated medical and healthcare infrastructure and market value contributors, changing lifestyle, and the rising burden of cancer, and other noncommunicable diseases (NCDs). The American Cancer Society stated that in 2018, about 9,220 new cases of colon cancer have diagnosed in the US. 

Europe would be the second-largest value contributor in the enteral feeding devices market owing to the Asia-Pacific would represent the profitable market growth during the forecast period due to growth in geriatric population, rising incidence of oral cancer, and increasing awareness about enteric feeding devices, and surging number of hospital admissions in China, India, Japan, and Australia. The World Health Organization stated that in 2018, the incidence of oral cancer was within the top three of all cancers in a few Pacific Asian countries.

The Middle East & Africa has the least share of the global enteral feeding devices market. In addition, the major market share of the region would be held by the Middle Eastern region due to developing healthcare system and medical infrastructure in the Arab countries.

Segmentation

The global enteral feeding devices market has been segmented into product, age group, indication, end user, and region.

By product, the market has been segmented into enteral feeding tubes, enteral feeding pumps, enteral syringes, administration sets, and consumables. The enteral feeding tubes segment is further categorized into enterostomy feeding tubes, nasoenteric feeding tubes, and oroenteric feeding tubes. The enterostomy feeding tubes segment is additionally divided into gastrostomy tubes, jejunostomy tubes, and gastrojejunostomy tubes. The nasoenteric feeding tubes segment is further classified into nasogastric feeding tubes, nasojejunal feeding tubes, and nasoduodenal feeding tubes. The enteral feeding pumps segment is expected to dominate the market throughout the forecast period due to low risk of complications with the use of feeding pumps, enhanced portable pump designs, and the increasing adoption of pumps in hospitals and home care settings.

On the basis of age group, the market has been divided into adults and pediatrics.

By indication, the market has been classified into cancer, gastrointestinal diseases, diabetes, neurological disorders, hypermetabolism, and others. The cancer segment is further categorized into gastrointestinal cancer, head & neck cancer, liver cancer, pancreatic cancer, esophageal cancer, and others.

Based on end user, the market has been categorized into hospitals, home care settings, and ambulatory surgery centers (ASCs).

Key Players

Some of the spearheading players in the global enteral feeding devices market are Medtronic plc, Cook Medical, B. Braun Melsungen AG, Abbott Laboratories, Boston Scientific Corporation, Becton, Dickinson and Company (BD), Fresenius Kabi AG, Danone Nutricia, Nestlé, CONMED Corporation, Moog, Inc., Halyard Health, Inc., and Vygon SA.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/enteral-feeding-devices-market-7828